Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-400
Closed -$246K 149
2025
Q1
$246K Hold
400
﹤0.01% 113
2024
Q4
$212K Hold
400
﹤0.01% 125
2024
Q3
$240K Hold
400
﹤0.01% 131
2024
Q2
$217K Hold
400
﹤0.01% 132
2024
Q1
$257K Hold
400
﹤0.01% 134
2023
Q4
$234K Hold
400
﹤0.01% 121
2023
Q3
$208K Buy
+400
New +$208K ﹤0.01% 126

Other funds holding CHE

Thomas Steyer's CHE Position: Q2 2025 in Review

Thomas Steyer sold out of Chemed (CHE) in Q2 2025, closing a stake of 400 shares — an estimated $246K sold.

Thomas Steyer first reported a position in CHE in Q3 2023 and held it in 7 quarters. The position peaked at $257K in Q1 2024. 538 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

  • Thomas Steyer reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
  • Thomas Steyer sold 400 Chemed shares in Q2 2025, an estimated $246K.
  • Thomas Steyer first reported a position in Chemed in Q3 2023 and held it in 7 quarters.
  • Thomas Steyer's Chemed position peaked at $257K in Q1 2024.
  • 538 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.